• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Thursday, February 25, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

DNA webs may drive lung pathology in severe COVID-19

Bioengineer by Bioengineer
September 14, 2020
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: © 2020 Radermecker et al. Originally published in Journal of Experimental Medicine. https://doi.org/10.1084/jem.20201012

Sticky webs of DNA released from immune cells known as neutrophils may cause much of the tissue damage associated with severe COVID-19 infections, according to two new studies published September 14 in the Journal of Experimental Medicine (JEM). The research, conducted by independent groups in Belgium and Brazil, suggests that blocking the release of these DNA webs could be a new therapeutic target for the management of severe forms of COVID-19.

While many people infected with the SARS-CoV-2 virus experience relatively mild symptoms, some patients mount an excessive inflammatory response that can damage the lungs and cause acute respiratory distress syndrome (ARDS), leading to low blood oxygen levels and, potentially, patient death. An early indicator of severe COVID-19 is an increased number of circulating neutrophils, a type of white blood cell. Neutrophils can catch and kill invading microbes by unwinding their DNA and extruding it from the cell to form sticky webs known as neutrophil extracellular traps (NETs). NETs can also damage surrounding tissue, however, and could therefore cause some of the lung pathology associated with severe COVID-19.

In one of the new studies, a research team from Liege University’s GIGA Institute led by Thomas Marichal, Cécile Oury, and Philippe Delvenne examined the lungs of patients who had succumbed to COVID-19 and found large numbers of NETs dispersed throughout the organ. The researchers saw many NETs in the airway compartment, where they often appeared to almost completely obstruct the small bronchioles and alveoli that mediate gas exchange. NETs were also formed at sites of inflammation located in the interstitial compartment between the alveoli and blood vessels, and could even be seen in the blood vessels themselves near tiny blood clots known as micro-thrombi that can restrict blood flow through the lungs and are a common pathological feature of severe COVID-19 patients.

“NETs can form a platform for the adhesion of platelets and other blood-clotting factors, but whether NETs actually contribute to the formation of COVID-19-associated pulmonary micro-thrombi will require further investigation,” says Thomas Marichal. “Altogether, our study supports the idea that targeting NETs in COVID-19 patients may help the clinical management of severe forms of COVID-19 by alleviating thrombotic events, excessive tissue-damaging inflammation, fibrosis, and airway obstruction.”

In the second study, a team of researchers led by Fernando Queiroz Cunha, Flavio Protasio Veras, and Thiago Mattar Cunha at the University of São Paulo also identified increased numbers of NETs in the lungs of severe COVID-19 patients and found that NET formation was elevated in COVID-19 patients’ blood plasma as well. Moreover, the researchers determined that SARS-CoV-2 can trigger the release of NETs by infecting neutrophils and replicating inside of them. NETs released from SARS-CoV-2-infected neutrophils induce the death of lung cells grown in the lab, the researchers found, but cell death is prevented if NET release is inhibited or the NETs are degraded by an enzyme that chews up DNA.

“Our study supports the use of inhibitors of NET synthesis or promoters of NET fragmentation as a strategy to ameliorate the organ damage associated with severe COVID-19,” says Fernando Queiroz Cunha.

###

Radermecker et al., 2020. J. Exp. Med. https://rupress.org/jem/article-lookup/doi/10.1084/jem.20201012?PR

Veras et al., 2020. J. Exp. Med. https://rupress.org/jem/article-lookup/doi/10.1084/jem.20201129?PR

About the Journal of Experimental Medicine

The Journal of Experimental Medicine (JEM) features peer-reviewed research on immunology, cancer biology, stem cell biology, microbial pathogenesis, vascular biology, and neurobiology. All editorial decisions are made by research-active scientists in conjunction with in-house scientific editors. JEM makes all of its content free online no later than six months after publication. Established in 1896, JEM is published by Rockefeller University Press. For more information, visit https://rupress.org/jem“>jem.org.

Visit our https://rupress.org/pages/newsroom“>Newsroom, and sign up for a weekly preview of articles to be published. Embargoed media alerts are for journalists only.

Follow JEM on Twitter at https://twitter.com/jexpmed“>@JExpMed and https://twitter.com/rockupress“>@RockUPress.

Media Contact
Ben Short
[email protected]

Tags: Cell BiologyCritical Care/Emergency MedicineImmunology/Allergies/AsthmaInfectious/Emerging DiseasesMedicine/HealthPulmonary/Respiratory MedicineVirology
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

Landmark study details sequencing of 64 full human genomes to better capture genetic diversity

February 25, 2021
IMAGE

UTEP survey reveals hidden health and wellness benefits of COVID-19 pandemic

February 25, 2021

A cat of all trades

February 25, 2021

Study: Bladder cancer is more advanced in South Texas

February 25, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    Terahertz accelerates beyond 5G towards 6G

    637 shares
    Share 255 Tweet 159
  • People living with HIV face premature heart disease and barriers to care

    81 shares
    Share 32 Tweet 20
  • Global analysis suggests COVID-19 is seasonal

    37 shares
    Share 15 Tweet 9
  • HIV: an innovative therapeutic breakthrough to optimize the immune system

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

cancerMedicine/HealthMaterialsInfectious/Emerging DiseasesClimate ChangeTechnology/Engineering/Computer ScienceCell BiologyPublic HealthGeneticsChemistry/Physics/Materials SciencesEcology/EnvironmentBiology

Recent Posts

  • Landmark study details sequencing of 64 full human genomes to better capture genetic diversity
  • Scientists use Doppler to peer inside cells
  • Nuclear physicists on the hunt for squeezed protons
  • Openly available toolkit to help lab-based coronavirus research
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In